ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2023 Earnings Call Transcript August 9, 2023
ADMA Biologics, Inc. reports earnings inline with expectations. Reported EPS is $-0.02 EPS, expectations were $-0.02.
Operator: Good afternoon, and welcome to the ADMA Biologics Second Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, August 9, 2023. [Operator Instructions]. Please be advised that this call is being recorded at the company’s request and will be available on the...
